Aramark is trading 10.15% down at $50.75, after falling from the September 21 close of $56.48, with no clear company-specific negative catalyst identified for September 22, 2026.
- Latest company news was a positive healthcare-services ranking announced September 21.
- The decline comes despite a generally firmer, mixed market backdrop, so broader sentiment does not clearly explain the move.
- Confidence is low pending additional filings or news.